Despite the pandemic, the medical staff retention and recruitment team has been busy.
Newsroom
The Issue: Baxter has made some changes to their parenteral nutrition (PN) product lines which affects products carried by NH: discontinuation of one product completely and addition of two new products to replace current formulations.
BC Emergency Health Services, in partnership with all BC health authorities, will be implementing a new standard operating guideline to improve the flow of patients
The BC Patient Safety & Quality Council (the Council) has launched a Clinician Fellowship in Health Care Quality! Applications will be accepted until May 14.
The Ministry of Health has identified and prioritized Clinical Extremely Vulnerable (CEV) populations to book appointments to receive COVID-19 vaccinations starting March 29, 2021.
All COVID-19 vaccines approved by health Canada for use in Canada, including the AstraZeneca/COVISHIELD vaccine are considered to be very safe products. A normal part of any vaccine rollout is careful monitoring of serious side effects or adverse events that may be associated with its use.
The shortage of tobramycin 0.3% ophthalmic ointment X 3.5 gram tubes has resolved and NH pharmacy now has access to an adequate ongoing supply.